Do you know how to get free insulin? We’ve found ways that low income diabetics can get free insulin for a year. This information can save lives, so please share this video.
More info (and applications) here:
Low Income Relief is a free information service that connects low income people across America with benefits, programs and resources in their local communities. We help millions of people per year save money and get free stuff!
Wondering how to get free insulin? I understand. Health care costs are literally killing diabetics, so knowing where to find insulin and cheap diabetic supplies are critically important. The average out-of-pocket cost for a diabetic American is $360, which is quite a sum when so many are struggling to afford rent and other necessities.
I’m Nicole from Low Income Relief, an information service that helps millions of people
save money and get free stuff every year.
We have gathered this information in honor of the many who have prematurely perished as a result of rationing their life-saving medication. You may be familiar with the stories of Shane Patrick Boyle, Maeghan Carter, Alex Raeshawn Smith and others who died tragic and preventable deaths from a lack of insulin. These deaths are heartbreaking and we mourn them.
People share memes about them all the time. Will you take a moment to share this video? We need help getting the word out to those who need it most. The more people who see this, the more lives we can save. There are more than 6,000 insulin fundraisers on GoFundMe as of this writing. This is a real, significant and ongoing problem.
This video has four parts:
3 Reasons Insulin is SO Expensive
How to Get FREE Insulin
How to Get Cheap Diabetic Supplies
Additional Tips to Save Money on Diabetes Care
There are 3 reasons insulin is so expensive.
The original insulin patent from the University of Toronto was sold for just $1, with the understanding that cheap insulin would be widely available.
Although insulin was affordable for a long time, the price has skyrocketed in recent years. In 2001, a 10-mm vial of Lantus was $40. By 2018, it was $275.
Why? There are three main reasons.
1. The manufacturing process has changed.
One reason that the price has changed is because of changing technologies and manufacturing processes. Synthetic ”human” insulin debuted in the 1980s and genetically modified ”analog” insulin was developed in the 1990s.
Analogs are more effective and predictable. They also take effect faster and are better at stabilizing blood sugar levels. Because they are so superior, 96% of US insulin prescriptions are for analog medications.
2. There is no competition.
Part of the reason that insulin is expensive is because there is a lack of competition. Three companies are responsible for 99% of the insulin market. In the United States, these companies are protected from generic competitors under patent law. The manufacturers continue to make tiny changes to their insulin products in order to extend their exclusivity rights. For example, Sanofi has filed 74 patent applications for Lantus alone.
3. The United States does not have price controls.
However, one of the main reasons that insulin is so expensive in the United States is simply because we do not have any price controls. Only 7% of the world’s diabetics live in North America, and yet North America is responsible for 52% of global insulin revenue.
There is a raging debate in the United States about how health care should be paid for. Some favor universal health care; others prefer our current system. Either way, we need cheap diabetic supplies and more reasonable insulin prices.
I, personally, agree with Dr. Ira B. Hirsch:
”[Insulin] is not a concierge drug that should be used by only those who can afford it. Insulin, in my view, is a right, not a privilege. And although I have no problems with the newest and ”greatest” insulins receiving whatever cost the market can bear, older insulins – yes, including the insulin analogs – ideally should be made available for all Americans at a reasonable cost.”
”This concept may seem counter-intuitive for many in the United States and perhaps (for insulin anyway) would make us look more like our neighbors and our friends in Europe. But to those who detest the thought of having our government involved in the distribution of insulin, I would say that I detest more the pain, suffering, cost, and potential death from diabetic ketoacidosis resulting from patients’ inability to afford insulin. Insulin should be readily available to anyone who needs it.”
–Transcript truncated due to length–